Gastrointestinal Adverse Reactions In clinical trials in adults for weight reduction, 73% of WEGOVY-treated patients and 47% of patients receiving placebo reported gastrointestinal adverse reactions, including severe reactions that were reported more frequently among patients receiving WEGOVY (4.1%) than placebo (0.9%)
Many mental health concerns can impact your weight loss journey, including: Anxiety Depression Eating disorders Stress Trauma And more With your care all on one platform, your doctor can easily refer you to MD Live mental health professionals where you can connect with a certified therapist in as little as a week
More than one in three New Yorkers who are Black or Hispanic struggle with obesity surpassing rates for every other racial or ethnic group
Key Features: Triple receptor agonist: GLP-1, GIP, and glucagon
Switching Medications: If discontinuation is required, a healthcare provider may recommend an alternative medication for diabetes or weight loss